Filing Details

Accession Number:
0000200406-10-000102
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-29 17:07:54
Reporting Period:
2010-11-24
Filing Date:
2010-11-29
Filing Date Changed:
2010-11-29
Accepted Time:
2010-11-29 17:07:54
Original Submission Date:
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1422968 S Sherilyn Mccoy Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick NJ 08933
Member, Executive Committee No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings
Common Stock Acquisiton 2010-11-24 15,000 $50.69 61,530
Common Stock Disposition 2010-11-24 15,000 $63.25 46,530
Common Stock Acquisiton 2010-10-30 285 $0.00 5,947
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 5 J Indirect Johnson & Johnson Stock Fund under the 401(k) Savings Plan
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2010-11-24 15,000 $0.00 15,000 $50.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2003-11-30 2010-11-29 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,316 Indirect ESOP under the 401(k) Savings Plan
Common Stock 17,292 Indirect By Husband
Footnotes
  1. Adjusted to reflect two-for-one stock split in 2001.
  2. Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (10/30/2010).
  3. Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (10/30/2010).
  4. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  5. Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant.
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 30 percentage points in 13 months Learn how!

Billionaire Hedge Funds
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!